HighTower Advisors
GSK icon

HighTower Advisors’s GSK GSK Stock Holding History

HighTower Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-100
Closed -$100 – 3541
2023
Q1 		$100 Buy
+100
New +$3.5K ﹤0.01% 3370

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

HighTower Advisors's GSK Position: Q1 2026 in Review

HighTower Advisors increased its GSK (GSK) stake by 1% in Q1 2026, buying an estimated $69.1K and bringing the position to 124,002 shares worth $6.84M. The position accounts for 0.01% of the portfolio, ranked #1045.

HighTower Advisors first reported a position in GSK in Q2 2013 and has held it in 51 quarters since. The position peaked at $57.1M in Q1 2022. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • HighTower Advisors held 124,002 shares of GSK worth $6.84M as of Q1 2026.
  • HighTower Advisors bought 1,275 GSK shares in Q1 2026, an estimated $69.1K.
  • GSK made up 0.01% of HighTower Advisors's portfolio in Q1 2026, its #1045 holding.
  • HighTower Advisors first reported a position in GSK in Q2 2013 and has held it in 51 quarters since.
  • HighTower Advisors's GSK position peaked at $57.1M in Q1 2022.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.